News | June 12, 2015

Fusion Ultrasound/Angiography Imaging May Improve Congenital Heart Disease Surgical Guidance

June 12, 2015 - Researchers announce the results of an early study that shows a fused fluoroscopic/ echocardiographic imaging (FFEI) system is feasible and provides improved guidance of interventional procedures in pediatric patients with congenital heart disease. An estimated 40,000 children are born in the United States each year with various forms of Congenital Heart Disease, with at least a quarter of those requiring some type of surgical intervention. The study is being presented at the 2015 American Society of Echocardiography (ASE) June 12- 16, in Boston.

While FFEI systems have been used in adult patients undergoing various cardiac procedures, its use has not been widely explored during catheterization procedures in pediatric patients.  In this study, the FFEI system was successfully used in 25 patients with congenital heart disease from January 2013 to January 2015. Twenty out of 25 procedures were graded as superior (80%) and none were graded as inferior. "These results show that procedural guidance using FFEI systems in congenital heart disease is not only feasible, but it also provides improved guidance over the current standard of care," noted Primary Investigator Pei-Ni Jone, M.D., of Children's Hospital Colorado. 

"Future studies might explore whether the FFEI system could decrease exposure to radiation with decreased use of fluoroscopy, which would be an important additional benefit in such a young population," Jone concluded.
 
Researchers on the study, "Procedural Guidance Using a Fused Fluoroscopic/Three Dimensional Echocardiography Imaging System in Congenital Heart Disease," include Pei-Ni Jone, Michael DiMaria, and Thomas Fagan from the University of Colorado School of Medicine in Aurora, Colo.; and John Bracken of Philips Research North America in Briarcliff Manor, N.Y.
 
Jone will present a poster based on this research Monday, June 15, 2015, during ASE at the Hynes Convention Center in Boston, Mass. 
 
For more information: www.asescientificsessions.org
 

Related Content

Patients Lack Information About Imaging Exams
News | Patient Engagement | February 14, 2018
Patients and their caregivers desire information about upcoming imaging examinations, but many are not getting it,...
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
PSMA PET-CT Clearly Differentiates Prostate Cancer from Benign Tissue

68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.

News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine...
New Policy Decisions Give Millions Access to HeartFlow FFRct Analysis
News | Cardiac Imaging | February 01, 2018
February 1, 2018 – HeartFlow announced that seven new commercial payers issued positive medical policies covering the
Small-Cell Lung Cancer Patients Face Barriers to Standard-of-Care Treatment
News | Lung Cancer | January 29, 2018
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the...
ASE Opens Enrollment for ImageGuideEcho Registry
News | Cardiovascular Ultrasound | January 29, 2018
January 29, 2018 — The American Society of Echocardiography (ASE) announced that ImageGuideEcho, a module under the I
An example of opto-acoustic breast imaging using the Seno system.

An example of opto-acoustic breast imaging using the Seno system.  

Feature | RSNA 2017 | January 29, 2018
January 26, 2017 — There were three high-impact clinical trials presented at the 2017 Radiological Society of North A
Advaxis Immunotherapy Offers Potential Combo Treatment for Anal Cancer
News | Radiation Therapy | January 26, 2018
January 26, 2018 — Advaxis Inc.
Overlay Init